Twist Bioscience to Present at Upcoming Virtual Conferences

Rhea-AI Summary

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience (NASDAQ: TWST) announced that CEO Emily M. Leproust, Ph.D., will present at several upcoming virtual investor conferences. These include the Truist Securities AI Symposium on March 1 at 9:00 a.m. ET and the Cowen 42nd Annual Health Care Conference on March 7, featuring a fireside chat at 2:10 p.m. ET and a Synthetic Biology Enabling Technologies Panel at 10:30 a.m. ET. The Cowen presentations will be webcast live, with replays available for 30 days post-event. Twist specializes in high-quality synthetic DNA products and applications across various industries.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the following upcoming virtual investor conferences:

• Truist Securities AI Symposium-Biotech & Tools Symposium on Tuesday, March 1; Applying the Power of AI to Synthetic Biology and Other Tools to Develop Therapeutics Panel at 9:00 a.m. Eastern Time.
• Cowen 42nd Annual Health Care Conference on Monday, March 7; fireside chat at 2:10 p.m. Eastern Time.
• Cowen 42nd Annual Health Care Conference on Monday, March 7; Synthetic Biology Enabling Technologies Panel at 10:30 a.m. Eastern Time.

The Cowen presentations will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the presentations will be archived for a period of 30 days following the conclusion of the live event.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005318/en/

For Twist Bioscience

Angela Bitting

SVP, Corporate Affairs

925- 202-6211

media@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

What is the date for Twist Bioscience's presentation at the Truist Securities AI Symposium?

Twist Bioscience will present at the Truist Securities AI Symposium on March 1 at 9:00 a.m. Eastern Time.

When is the Cowen 42nd Annual Health Care Conference presentation by Twist Bioscience?

Twist Bioscience will participate in the Cowen 42nd Annual Health Care Conference on March 7.

What time is the fireside chat at the Cowen 42nd Annual Health Care Conference for Twist Bioscience?

The fireside chat for Twist Bioscience at the Cowen conference is scheduled for 2:10 p.m. Eastern Time on March 7.

Will Twist Bioscience's presentations be available for replay?

Yes, the Cowen presentations will be webcast live and available for replay for 30 days after the live event.

What does Twist Bioscience specialize in?

Twist Bioscience specializes in high-quality synthetic DNA products and applications for various industries, including healthcare and agriculture.